Treat the tributary veins in the same sitting, or wait and see? Doing it at once cut re-intervention by two thirds

Varicose veins are rarely one vein. There is usually an incompetent trunk beneath the skin driving the problem, and a network of visible tributaries fed by it. Closing the trunk is the part everyone agrees on. What to do about the tributaries, and when, is a question with two defensible answers and now some evidence.

The two strategies#

The combined approach treats everything in one sitting: ablate the trunk, then remove or inject the tributaries immediately. The staged approach ablates the trunk and waits, on the reasoning that once the pressure driving the tributaries is gone some of them shrink on their own and never need treating.

Both arguments are about the same patient. One says do everything now and spare them a second visit; the other says wait and spare some of them a procedure entirely.

What the pooled trials found#

A systematic review and meta-analysis published in Phlebology pooled six randomised controlled trials covering 432 patients, comparing concomitant combined treatment against ablation alone.

Cutting re-intervention to a third, with better early quality of life and better twelve-month severity scores and no additional harm, is about as clean a result as this literature produces.

Why the staged case is not defeated by it#

The authors' own framing is explicitly a value judgement rather than a finding: from a patient-centred perspective, they write, additional procedures represent a treatment burden. That is a reasonable position and it is a position, not a measurement. A patient who would rather have one longer procedure and be done will read the result one way; a patient who would rather have the smallest intervention that might suffice will read it the other.

How much evidence this actually is#

Six trials and 432 patients is a small base for a question that arises in most varicose vein consultations. Pooled with random-effects models across trials that differ in technique, in which tributary treatment was used, and in how re-intervention was defined, the confidence intervals reflect that: a risk ratio running from 0.18 to 0.62 establishes the direction firmly and the size loosely.

The clinical severity difference is also worth reading at its true scale. A mean difference of 0.86 on the Venous Clinical Severity Score is statistically clear and clinically modest — the score runs to 30, and most patients do not notice a point of it. The re-intervention finding is the one carrying the practical weight here.

For a patient, the useful version is short. Having the visible veins dealt with at the same appointment as the underlying one makes it about two thirds less likely they will need to come back for another procedure, does not appear to hurt more or carry more complications, and may treat some veins that would have settled by themselves. All three of those are true at once.